세계의 식품 알레르기 진단 및 치료 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Food Allergy Diagnostics And Therapeutics Market is presumed to reach the market size of nearly USD 17.56 Billion by 2032 from USD 8.36 Billion in 2023 with a CAGR of 8.59% under the study period 2024-2032.

Food allergy diagnostics and therapeutics encompass a range of tests and treatments designed to identify and manage food allergies, which are immune responses triggered by the ingestion of certain foods. Diagnostic tools include skin prick tests, blood tests, and oral food challenges, which help determine specific allergens and the severity of the allergic reaction. Therapeutic approaches aim to mitigate allergic responses, including allergen avoidance strategies, emergency medications like epinephrine, and emerging treatments like oral immunotherapy. These interventions are crucial for managing food allergies and improving the quality of life for affected individuals by reducing the risk of severe allergic reactions and enhancing overall health outcomes.

MARKET DYNAMICS

The global food allergy diagnostics & therapeutics market is fuelled by the rising prevalence of food allergies and the growing demand for effective management solutions. Advances in diagnostic technologies, such as multiplex assays and genetic testing, provide more accurate and comprehensive identification of allergens. The development of novel therapeutic approaches, including allergen immunotherapy and biologics, offers new opportunities for treatment and improved patient outcomes. The propelling awareness of food allergies and the need for personalized management strategies are fuelling demand for specialized diagnostics and therapies. Additionally, regulatory support and funding for research into food allergy treatments are contributing to the growth of the food allergy diagnostics & therapeutics market. The expansion of healthcare infrastructure and the increasing focus on preventive care also create opportunities for market development & innovation. However, high treatment costs and limited availability of advanced diagnostics may hinder the growth of the food allergy diagnostics and therapeutics market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Food Allergy Diagnostics And Therapeutics. The growth and trends of Food Allergy Diagnostics And Therapeutics industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Food Allergy Diagnostics And Therapeutics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Diagnostics (Instruments, Consumables, Services, Tests (In Vivo/Skin (Skin Prick Test, Patch Test), In Vitro))
• Therapeutics (Antihistamines, Epinephrine Auto-Injector)

By Allergen Source

• Peanuts
• Milk
• Eggs
• Fish
• Shellfish
• Tree Nuts
• Wheat
• Soy
• Others

By End-use

• Hospitals And Clinics
• Academic Research Institutes
• Diagnostics Laboratories

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Food Allergy Diagnostics And Therapeutics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Food Allergy Diagnostics And Therapeutics market include Astellas Pharma Inc., Aimmune Therapeutics, Meridian Medical Technologies, Medeca Pharma AB, BioMeriux SA, Omega Diagnostics Group PLC, Cambridge Allergy Ltd, Immunomic Therapeutics Inc, Prota Therapeutics Pty Ltd, ALK-Abello Ltd, Hycor Biomedical, HOB Biotech Group Corp. Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Allergen Source
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Diagnostics (Instruments, Consumables, Services, Tests (In Vivo/Skin (Skin Prick Test, Patch Test), In Vitro)) Historic and Forecast Sales By Regions
• 5.4. Therapeutics (Antihistamines, Epinephrine Auto-Injector) Historic and Forecast Sales By Regions

6. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY ALLERGEN SOURCE

• 6.1. Overview By Allergen Source
• 6.2. Historical and Forecast Data Analysis By Allergen Source
• 6.3. Peanuts Historic and Forecast Sales By Regions
• 6.4. Milk Historic and Forecast Sales By Regions
• 6.5. Eggs Historic and Forecast Sales By Regions
• 6.6. Fish Historic and Forecast Sales By Regions
• 6.7. Shellfish Historic and Forecast Sales By Regions
• 6.8. Tree Nuts Historic and Forecast Sales By Regions
• 6.9. Wheat Historic and Forecast Sales By Regions
• 6.10. Soy Historic and Forecast Sales By Regions
• 6.11. Others Historic and Forecast Sales By Regions

7. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-use
• 7.2. Historical and Forecast Data Analysis By End-use
• 7.3. Hospitals And Clinics Historic and Forecast Sales By Regions
• 7.4. Academic Research Institutes Historic and Forecast Sales By Regions
• 7.5. Diagnostics Laboratories Historic and Forecast Sales By Regions

8. GLOBAL FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS COMPANIES

• 9.1. Food Allergy Diagnostics And Therapeutics Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF FOOD ALLERGY DIAGNOSTICS AND THERAPEUTICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Astellas Pharma Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Aimmune Therapeutics
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Meridian Medical Technologies
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Medeca Pharma AB
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. BioMeriux SA
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Omega Diagnostics Group PLC
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. Cambridge Allergy Ltd
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Immunomic Therapeutics Inc
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Prota Therapeutics Pty Ltd
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. ALK-Abello Ltd
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Hycor Biomedical
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments
• 10.14. HOB Biotech Group Corp. Ltd
  • 10.14.1 Company Overview
  • 10.14.2 Company Revenue
  • 10.14.3 Products
  • 10.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies